ACADIA Pharmaceuticals
Utility Patent Applications

Last updated:

List of all ACADIA Pharmaceuticals patents 21 in total

Status Patent
Application
Utility: SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: FORMULATIONS OF PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 23 Jun 2022
Application
Utility: METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC External link
Filling date: 12 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using Same External link
Filling date: 12 Sep 2025 Issue date: 19 May 2022
Application
Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C External link
Filling date: 12 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: METHODS OF TREATING DEPRESSION, ANXIETY AND SEXUAL DYSFUNCTION USING THE COMPOUND PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES External link
Filling date: 12 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: FORMULATIONS OF PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: METHODS FOR TREATING DEMENTIA RELATED PSYCHOSIS External link
Filling date: 12 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES External link
Filling date: 12 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: FORMULATIONS OF PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 18 Mar 2021
Application
Utility: SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES External link
Filling date: 12 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: PIMAVANSERIN ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE PSYCHOSIS External link
Filling date: 12 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: FORMULATIONS OF PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM External link
Filling date: 12 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM External link
Filling date: 12 Sep 2025 Issue date: 28 May 2020
Application
Utility: COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS External link
Filling date: 12 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: PIMAVANSERIN FOR TREATING IMPULSE CONTROL DISORDER External link
Filling date: 12 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: FORMULATIONS OF PIMAVANSERIN External link
Filling date: 12 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS External link
Filling date: 12 Sep 2025 Issue date: 1 Aug 2019

Showing 1 to 21 of 21 patents.